Rektumkarzinom

Literatur

• 1 Engelen S M, Beets G L, Beets-Tan R G. Role of preoperative local and distant staging in rectal cancer.  Onkologie. 2007;  30 141-145
• 2 Beets-Tan R G, Beets G L, Vliegen R F. et al . Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery.  Lancet. 2001;  357 497-504
• 3 Beets-Tan R G, Beets G L. Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin?.  Int J Colorectal Dis. 2003;  18 385-391
• 4 Nivatvongs S. Surgical management of early colorectal cancer.  World J Surg. 2000;  24 1052-1055
• 5 Lippert H, Gastinger I. Versorgung von Patienten mit Rektumkarzinomen in Deutschland.  Dtsch Ärztebl. 2006;  41 B2346-B2351
• 6 Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy.  Int J Colorectal Dis. 1997;  12 19-23
• 7 Swedish Rectal Cancer Trial . Improved survival with preoperative radiotherapy in respectable rectal carcinoma.  N Engl J Med. 1997;  336 980-987
• 8 Kapiteijn E, Marijnen C AM, Nagtegaal I D. et al . Preoperative Radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med. 2001;  345 638-649
• 9 Marijnen C AM, Nagtegaal I D, Kranenbarg E K. et al . No downstaging after short-term preoperative radiotherapy in rectal cancer patients.  J Clin Oncol. 2001;  19 1976-1984
• 10 Marijnen C AM, van de Velde C J. et al . Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial.  J Clin Oncol. 2005;  23 1847-1858
• 11 Peeters K CMJ, van de Velde C JH, Leer J WH. et al . Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - A Dutch Colorectal Cancer Group Study.  J Clin Oncol. 2005;  23 6199-6206
• 12 Marijnen C AM, Kapiteijn E, van de Velde C J. et al . Acute side effects and complication after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial.  J Clin Oncol. 2000;  20 817-825
• 13 Sauer R, Becker H, Hohenberger W. et al . Preoperative versus postoperative chemoradiotherapy for rectal cancer.  N Engl J Med. 2004;  351 1731-1740
• 14 Bosset J F, Collette L, Calais G. et al . Chemotherapy with preoperative radiotherapy in rectal cancer.  N Engl J Med. 2006;  355 1114-1123
• 15 Gerard J P, Conroy T, Bonnetain F. et al . Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3 - 4 rectal cancers: results of FFCD 9203.  J Clin Oncol. 2006;  24 4620-4625
• 16 Bujko K, Nowacki M P, Nasierowska-Guttmejer A. et al . Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.  Radiother Oncol. 2004;  72 15-24
• 17 Bujko K, Nowacki M P, Nasierowska-Guttmejer A. et al . Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.  Br J Surg. 2006;  93 1215-1223
• 18 Rodel C, Sauer R. Integration of Novel Agents into Combined-Modality Treatment for Rectal Cancer Patients.  Strahlenther Onkol. 2007;  183 227-235
• 19 Cunningham D, Pyrhonen S, James R D. et al . Randomized trial of irinotecan plus supportive care versus supportive care alone after fluoruracil failure for patients with metastatic colorectal cancer.  Lancet. 1998;  352 1413-1418
• 20 Rougier P, VanCutsem E, Bajetta E. et al . Randomized trial of irinotecan versus fluoruracil by coninuous infusion after fluoruracil failure in patients with metastatic colorectal cancer.  Lancet. 1998;  352 1407-1412
• 21 Goldberg R M, Sargent D J, Morton R F. et al . A randomized controlled trial of Fluorouracil plus Leucovorin, Irinotecan and Oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.  J Clin Oncol. 2004;  22 23-30
• 22 Tournigand C, Andre T, Achille E. et al . FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.  J Clin Oncol. 2004;  22 229-237
• 23 Hoff P M, Ansari R, Batist G. et al . Comparison of oral capecitabine versus intravenous fluoruracil plus leucovorin as first line therapy in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study.  J Clin Oncol. 2001;  19 2282-2292
• 24 Van Cutsem E, Twelfes C, Cassidy J. et al . Oral capecitabine compared with intravenous fluoruracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study.  J Clin Oncol. 2001;  19 4097-4106
• 25 Porschen T, Arkenau H T, Kubicka S. et al . Capecitabine plus Oxaliplatin compared with Fluorouracil and Leucovorin plus Oxaliplatin: A Randomized comparison in metastatic colorectal caner - A final report of the AIO Colorectal Study Group.  J Clin Oncol. [Published ahead of Print on Juni 4, 2007]; 
• 26 Cunningham D, Humblet Y, Siena S. et al . Cetuximab montherapy and Cetuximab plus Irinotecan in Irinotecan-refractory metastatic colorectal cancer.  N Engl J Med. 2004;  351 337-345
• 27 Hurwitz H, Fehrenbacher L, Novotny . et al . Bevacizumab plus Irinotecan, Fluorouracil and Leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
• 28 Grothey A, Sargent D, Goldberg R M. et al . Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.  J Clin Oncol. 2004;  22 1209-1214